TFEB and Parkinson disease: Accumulating evidence has shown that TFEB overexpression or its pharmacological activation in cellular and mouse models of AD and PD can reduce protein aggregation and improve neurological functions23–28, indicating that proper regulation of TFEB activity is critical for maintaining healthy neurons.